Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - April 4, 2024 Category: Cancer & Oncology Authors: Yonggang Li Zhe Xu Yuanyuan Li Tianjun Jiang Fanping Meng Junliang Fu Lei Huang Fengchao Wang Xia Wang Fusheng Wang Source Type: research